Every few months for the past three years, Jeff Vierstra has been receiving infusions in his spine that target and disable a ...
The College of Agriculture and Life Sciences is celebrating four former students recently recognized with the Distinguished ...
Forma Life Sciences, which inherited BioDuro’s California production operations earlier this year, has officially launched as a CDMO with a focus on oral solid-dosage drugs. The new contract ...
A rendering shows a special floor at The Landing where built-out lab/office 'spec space' is available for tenants who prefer immediate move-in. Demand for specialized talent in the life sciences ...
Jonathan Wosen is STAT’s West Coast biotech & life sciences reporter. You can reach Jonathan on Signal at jwosen.27. When Kulindu Vithanachchi’s phone lit up with an update from the National Science ...
Artificial intelligence is no longer a promise of the future in the life sciences. It is quickly becoming a core competency for launching, scaling, and sustaining therapies. As the volume of data ...
This is the center of the Heart Nebula or IC-1805 in the center is a cluster of stars known as Melotte 15. It is located in the Perseus Arm of the Galaxy in the constellation Cassiopeia. This is the ...
A Dalai Lama once said that our prime purpose in this life is to help others – and he may have been right. Scientists have found that having a positive impact on other people seems to be a key element ...
After two years of layoffs and funding pullbacks, South San Francisco’s life science industry is showing stronger signs of a comeback— though more mega-rounds and less early-stage funding could ...
BlueRidge Life Sciences (“BlueRidge”), a leading life sciences consulting and services platform and a portfolio company of Renovus Capital Partners, today announced the acquisition of Design Science, ...
Life sciences mergers and acquisitions surged back in force in 2025, as pharmaceutical and med-tech companies moved aggressively to shore up pipelines and offset looming revenue losses, according to ...
Caris Life Sciences has transitioned to self-funded growth with positive EBITDA and free cash flow, driven by strong MI segment performance. The Roche partnership validates CAI's discovery platform, ...